PL1833810T3 - Krystaliczne modyfikacje N-alfa-(2,4,6-triizopropylofenylosulfonylo)-3-hydroksyamidyno-(L)- fenyloalanino-4-etoksykarbonylopiperazydu i/lub jego soli - Google Patents
Krystaliczne modyfikacje N-alfa-(2,4,6-triizopropylofenylosulfonylo)-3-hydroksyamidyno-(L)- fenyloalanino-4-etoksykarbonylopiperazydu i/lub jego soliInfo
- Publication number
- PL1833810T3 PL1833810T3 PL05808401T PL05808401T PL1833810T3 PL 1833810 T3 PL1833810 T3 PL 1833810T3 PL 05808401 T PL05808401 T PL 05808401T PL 05808401 T PL05808401 T PL 05808401T PL 1833810 T3 PL1833810 T3 PL 1833810T3
- Authority
- PL
- Poland
- Prior art keywords
- ethoxycarbonylpiperazide
- triisopropylphenylsulfonyl
- hydroxyamidino
- phenylalanine
- alpha
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
- C07D295/205—Radicals derived from carbonic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
- C07D295/182—Radicals derived from carboxylic acids
- C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Oncology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Communicable Diseases (AREA)
- Pain & Pain Management (AREA)
- Ophthalmology & Optometry (AREA)
- Dermatology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102004057195A DE102004057195A1 (de) | 2004-11-26 | 2004-11-26 | Kristalline Modifikationen von N-Alpha-(2,4,6-Triisopropylphenylsulfonyl)-3-hydroxyamidino-(L)-phenylalanin-4-ethoxycarbonylpiperazid und/oder Salzen davon |
EP05808401.3A EP1833810B1 (de) | 2004-11-26 | 2005-11-24 | Kristalline modifikationen von n-alpha-(2,4,6-triisopropylphenylsulfonyl)-3-hydroxyamidino-(l)-phenylalanin-4-ethoxycarbonylpiperazid und/oder salzen davon |
PCT/EP2005/012589 WO2006056448A1 (de) | 2004-11-26 | 2005-11-24 | KRISTALLINE MODIFIKATIONEN VON N-α-(2,4,6-TRIISOPROPYLPHENYLSULFONYL)-3-HYDROXYAMIDINO-(L)-PHENYLALANIN-4-ETHOXYCARBONYLPIPERAZID UND/ODER SALZEN DAVON |
Publications (1)
Publication Number | Publication Date |
---|---|
PL1833810T3 true PL1833810T3 (pl) | 2018-01-31 |
Family
ID=35811673
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL05808401T PL1833810T3 (pl) | 2004-11-26 | 2005-11-24 | Krystaliczne modyfikacje N-alfa-(2,4,6-triizopropylofenylosulfonylo)-3-hydroksyamidyno-(L)- fenyloalanino-4-etoksykarbonylopiperazydu i/lub jego soli |
Country Status (17)
Country | Link |
---|---|
US (2) | US7713980B2 (pl) |
EP (1) | EP1833810B1 (pl) |
JP (1) | JP5054538B2 (pl) |
KR (2) | KR101455788B1 (pl) |
CN (1) | CN1989118B (pl) |
AU (1) | AU2005308977B2 (pl) |
BR (1) | BRPI0514823A (pl) |
CA (1) | CA2581959C (pl) |
DE (1) | DE102004057195A1 (pl) |
DK (1) | DK1833810T3 (pl) |
ES (1) | ES2645567T3 (pl) |
HU (1) | HUE037259T2 (pl) |
MX (1) | MX2007001420A (pl) |
PL (1) | PL1833810T3 (pl) |
PT (1) | PT1833810T (pl) |
RU (1) | RU2388754C2 (pl) |
WO (1) | WO2006056448A1 (pl) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103040815B (zh) * | 2011-10-13 | 2014-12-10 | 中国科学院上海药物研究所 | 一类2,4,6-三异丙基苯类化合物在制备治疗糖尿病的药物中的用途 |
CN105566327A (zh) * | 2014-10-09 | 2016-05-11 | 江苏恒瑞医药股份有限公司 | 一种jak激酶抑制剂的硫酸氢盐的i型结晶及其制备方法 |
MX2018004309A (es) * | 2015-10-06 | 2018-05-22 | Redhill Biopharma Ltd | Terapias combinadas para tratar el cancer. |
CA3117559C (en) * | 2018-10-31 | 2023-09-26 | Les Laboratoires Servier | Hydrogen sulfate salt of a bcl-2 inhibitor, related crystalline form,method for preparing the same and pharmaceutical compositions containing the same |
WO2021181157A1 (en) | 2020-03-10 | 2021-09-16 | Redhill Biopharma Ltd. | Treatment of coronavirus infection |
US11471448B2 (en) | 2020-12-15 | 2022-10-18 | Redhill Biopharma Ltd. | Sphingosine kinase 2 inhibitor for treating coronavirus infection in moderately severe patients with pneumonia |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002074756A2 (de) | 2001-03-21 | 2002-09-26 | Pentapharm Ag | Urokinase-inhibitoren |
SI21137A (sl) | 2002-01-24 | 2003-08-31 | LEK, tovarna farmacevtskih in kemičnih izdelkov, d.d. | Derivati azafenilalanina |
CH695999A5 (de) | 2002-02-28 | 2006-11-15 | Wilex Ag | Verfahren zur Herstellung von 3- Amidinophenylalanin-Derivaten. |
WO2004011449A2 (de) | 2002-07-25 | 2004-02-05 | Wilex Ag | Verfahren zur herstellung von phenylalanin-derivaten |
DE10323898A1 (de) | 2003-05-26 | 2004-12-23 | Wilex Ag | Hydroxyamidin- und Hydroxyguanidin-Verbindungen als Urokinase-Hemmstoffe |
DE102004045720A1 (de) * | 2004-09-21 | 2006-03-23 | Wilex Ag | Stabile Dosierungsform von Phenylalanin-Derivaten |
-
2004
- 2004-11-26 DE DE102004057195A patent/DE102004057195A1/de not_active Ceased
-
2005
- 2005-11-24 CA CA2581959A patent/CA2581959C/en active Active
- 2005-11-24 EP EP05808401.3A patent/EP1833810B1/de active Active
- 2005-11-24 KR KR1020137011330A patent/KR101455788B1/ko active IP Right Grant
- 2005-11-24 HU HUE05808401A patent/HUE037259T2/hu unknown
- 2005-11-24 US US11/664,266 patent/US7713980B2/en active Active
- 2005-11-24 ES ES05808401.3T patent/ES2645567T3/es active Active
- 2005-11-24 CN CN2005800249441A patent/CN1989118B/zh active Active
- 2005-11-24 MX MX2007001420A patent/MX2007001420A/es active IP Right Grant
- 2005-11-24 WO PCT/EP2005/012589 patent/WO2006056448A1/de active Application Filing
- 2005-11-24 JP JP2007541847A patent/JP5054538B2/ja active Active
- 2005-11-24 BR BRPI0514823-5A patent/BRPI0514823A/pt not_active Application Discontinuation
- 2005-11-24 DK DK05808401.3T patent/DK1833810T3/da active
- 2005-11-24 PT PT58084013T patent/PT1833810T/pt unknown
- 2005-11-24 AU AU2005308977A patent/AU2005308977B2/en active Active
- 2005-11-24 PL PL05808401T patent/PL1833810T3/pl unknown
- 2005-11-24 KR KR1020077004417A patent/KR101311329B1/ko active IP Right Grant
- 2005-11-24 RU RU2007123712/04A patent/RU2388754C2/ru active
-
2010
- 2010-03-29 US US12/749,140 patent/US8492385B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
PT1833810T (pt) | 2017-12-11 |
US20080058346A1 (en) | 2008-03-06 |
WO2006056448A1 (de) | 2006-06-01 |
JP5054538B2 (ja) | 2012-10-24 |
DE102004057195A1 (de) | 2006-06-01 |
US8492385B2 (en) | 2013-07-23 |
AU2005308977B2 (en) | 2011-09-15 |
US20100266679A1 (en) | 2010-10-21 |
KR101311329B1 (ko) | 2013-09-25 |
HUE037259T2 (hu) | 2018-08-28 |
RU2007123712A (ru) | 2009-01-10 |
DK1833810T3 (da) | 2017-12-04 |
BRPI0514823A (pt) | 2008-06-24 |
KR20070083507A (ko) | 2007-08-24 |
MX2007001420A (es) | 2007-04-19 |
JP2008521764A (ja) | 2008-06-26 |
EP1833810B1 (de) | 2017-08-30 |
AU2005308977A1 (en) | 2006-06-01 |
CN1989118B (zh) | 2012-11-14 |
CN1989118A (zh) | 2007-06-27 |
EP1833810A1 (de) | 2007-09-19 |
RU2388754C2 (ru) | 2010-05-10 |
KR20130066700A (ko) | 2013-06-20 |
CA2581959A1 (en) | 2006-06-01 |
US7713980B2 (en) | 2010-05-11 |
CA2581959C (en) | 2013-08-06 |
KR101455788B1 (ko) | 2014-11-04 |
ES2645567T3 (es) | 2017-12-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL192241A (en) | A process for making 4 - (benzimidazolylmethylamino) - benzamides and their salts | |
TWI349666B (en) | Substituted morpholine and thiomorpholine derivatives | |
TWI372752B (en) | Pyrazinecarboxamide derivatives and plant disease controlling agents containing the same | |
IL184059A0 (en) | Crystal and salt of 1-cyclopropylmethyl-4-[2-(3,3,5,5)-tetramethylcyclohexylphenyl]piperazine | |
TWI349649B (en) | Structurally modified titanium dioxides | |
IL195346A0 (en) | Novel heterocyclic compound or salt thereof and intermediate thereof | |
HUE056718T2 (hu) | Hatóanyag (delafloxacin) meglumin sója és ennek kristályos formái | |
IL180905A0 (en) | Lercanidipine salts | |
IL175123A0 (en) | Crystalline ammonium salts of rosuvastatin | |
PL378587A1 (pl) | Sposób wytwarzania (S)-(-)-2-amino-6-n-propyloamino-4,5,6,7-tetrahydrobenzotiazolu i/lub jego soli | |
ZA200702380B (en) | Substituted heterocyclic compounds and uses thereof | |
IL178461A0 (en) | Substituted 4-alkyl -and 4-alkanoyl-piperidine derivatives and their use as neurokinin antagonists | |
EP1773339A4 (en) | CRYSTALLINE FORM OF DONEPEZIL HYDROCHLORIDE | |
PL1833810T3 (pl) | Krystaliczne modyfikacje N-alfa-(2,4,6-triizopropylofenylosulfonylo)-3-hydroksyamidyno-(L)- fenyloalanino-4-etoksykarbonylopiperazydu i/lub jego soli | |
EP1898755A4 (en) | PILLAR PINE SELECTION AND POVERTY EVALUATION | |
EP1767531A4 (en) | MEDICINAL COMPOSITIONS CONTAINING 6-HYDROXYBENZBROMARONE OR SALTS THEREOF | |
EP1852432A4 (en) | NITROGENIC HETEROCYCLIC COMPOUND AND THEIR MEDICAL USE | |
EP1623972A4 (en) | SOLID N-ACYLALANINE OR SALTS THEREOF | |
ZA200804816B (en) | Pyrazinecarboxamide derivatives and plant disease controlling agents containing the same | |
IL186221A0 (en) | Crystalline rosuvastatin intermediate | |
HK1127862A1 (en) | Piperazine compound and pyridine compound | |
AU2003232062A8 (en) | Heterocyclic amine diol compounds and their biocidal derivatives | |
IL180702A0 (en) | Dimeric piperidine derivatives | |
HU0401551D0 (en) | Polisulfated glycosides and salts thereof | |
SI1877390T1 (sl) | Spojine benzizoksazol piperazina in metode uporabe le teh |